Literature DB >> 32235271

The varying roles of macrophages in kidney injury and repair.

Yi Wen1, Steven D Crowley.   

Abstract

PURPOSE OF REVIEW: Macrophages play an important role in regulating homeostasis, kidney injury, repair, and tissue fibrogenesis. The present review will discuss recent advances that explore the novel subsets and functions of macrophage in the pathogenesis of kidney damage and hypertension. RECENT
FINDINGS: Macrophages differentiate into a variety of subsets in microenvironment-dependent manner. Although the M1/M2 nomenclature is still applied in considering the pro-inflammatory versus anti-inflammatory effects of macrophages in kidney injury, novel, and accurate macrophage phenotypes are defined by flow cytometric markers and single-cell RNA signatures. Studies exploring the crosstalk between macrophages and other cells are rapidly advancing with the additional recognition of exosome trafficking between cells. Using murine conditional mutants, actions of macrophage can be defined more precisely than in bone marrow transfer models. Some studies revealed the opposing effects of the same protein in renal parenchymal cells and macrophages, highlighting a need for the development of cell-specific immune therapies for translation.
SUMMARY: Macrophage-targeted therapies hold potential for limiting kidney injury and hypertension. To realize this potential, future studies will be required to understand precise mechanisms in macrophage polarization, crosstalk, proliferation, and maturation in the setting of renal disease.

Entities:  

Mesh:

Year:  2020        PMID: 32235271      PMCID: PMC7731284          DOI: 10.1097/MNH.0000000000000595

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   3.416


  124 in total

1.  Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury.

Authors:  Alaa S Awad; Gilbert R Kinsey; Konstantine Khutsishvili; Ting Gao; W Kline Bolton; Mark D Okusa
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-31

2.  Involvement of matrix metalloproteinase-2 in the development of renal interstitial fibrosis in mouse obstructive nephropathy.

Authors:  Xuanyi Du; Akira Shimizu; Yukinari Masuda; Naomi Kuwahara; Takashi Arai; Mitue Kataoka; Masaaki Uchiyama; Tomohiro Kaneko; Toshio Akimoto; Yasuhiko Iino; Yuh Fukuda
Journal:  Lab Invest       Date:  2012-05-21       Impact factor: 5.662

Review 3.  Monocyte chemoattractant protein-1 and the kidney.

Authors:  Hermann Haller; Anna Bertram; Felix Nadrowitz; Jan Menne
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-01       Impact factor: 2.894

4.  Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.

Authors:  Li Chen; Xia Zhou; Lucy X Fan; Ying Yao; Katherine I Swenson-Fields; Mihaela Gadjeva; Darren P Wallace; Dorien J M Peters; Alan Yu; Jared J Grantham; Xiaogang Li
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

5.  Nicotine Mediates CD161a+ Renal Macrophage Infiltration and Premature Hypertension in the Spontaneously Hypertensive Rat.

Authors:  Sailesh C Harwani; Jason Ratcliff; Fayyaz S Sutterwala; Zuhair K Ballas; David K Meyerholz; Mark W Chapleau; Francois M Abboud
Journal:  Circ Res       Date:  2016-09-22       Impact factor: 17.367

6.  Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway.

Authors:  Yannick Le Meur; Gregory H Tesch; Prudence A Hill; Wei Mu; Rita Foti; David J Nikolic-Paterson; Robert C Atkins
Journal:  J Leukoc Biol       Date:  2002-09       Impact factor: 4.962

7.  Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations.

Authors:  Shuei Liong Lin; Ana P Castaño; Brian T Nowlin; Mark L Lupher; Jeremy S Duffield
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

8.  Opposing actions of renal tubular- and myeloid-derived porcupine in obstruction-induced kidney fibrosis.

Authors:  Xiaohan Lu; Nathan P Rudemiller; Jiafa Ren; Yi Wen; Bo Yang; Robert Griffiths; Jamie R Privratsky; Babita Madan; David M Virshup; Steven D Crowley
Journal:  Kidney Int       Date:  2019-07-31       Impact factor: 10.612

Review 9.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.

Authors:  Tamás Rőszer
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

10.  Transcriptome-based network analysis reveals a spectrum model of human macrophage activation.

Authors:  Jia Xue; Susanne V Schmidt; Jil Sander; Astrid Draffehn; Wolfgang Krebs; Inga Quester; Dominic De Nardo; Trupti D Gohel; Martina Emde; Lisa Schmidleithner; Hariharasudan Ganesan; Andrea Nino-Castro; Michael R Mallmann; Larisa Labzin; Heidi Theis; Michael Kraut; Marc Beyer; Eicke Latz; Tom C Freeman; Thomas Ulas; Joachim L Schultze
Journal:  Immunity       Date:  2014-02-13       Impact factor: 31.745

View more
  10 in total

1.  Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation.

Authors:  Nathalie Niyonzima; Jubayer Rahman; Natalia Kunz; Erin E West; Tilo Freiwald; Jigar V Desai; Nicolas S Merle; Alexandre Gidon; Bjørnar Sporsheim; Michail S Lionakis; Kristin Evensen; Beate Lindberg; Karolina Skagen; Mona Skjelland; Parul Singh; Markus Haug; Marieta M Ruseva; Martin Kolev; Jack Bibby; Olivia Marshall; Brett O'Brien; Nigel Deeks; Behdad Afzali; Richard J Clark; Trent M Woodruff; Milton Pryor; Zhi-Hong Yang; Alan T Remaley; Tom E Mollnes; Stephen M Hewitt; Bingyu Yan; Majid Kazemian; Máté G Kiss; Christoph J Binder; Bente Halvorsen; Terje Espevik; Claudia Kemper
Journal:  Sci Immunol       Date:  2021-12-24

Review 2.  Sorting nexins: role in the regulation of blood pressure.

Authors:  Juan Huang; Andrew C Tiu; Pedro A Jose; Jian Yang
Journal:  FEBS J       Date:  2021-11-30       Impact factor: 5.622

Review 3.  Nano-Technological Approaches for Targeting Kidney Diseases With Focus on Diabetic Nephropathy: Recent Progress, and Future Perspectives.

Authors:  Bo Lin; Ying-Yu Ma; Jun-Wei Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

4.  TLR2/caspase-5/Panx1 pathway mediates necrosis-induced NLRP3 inflammasome activation in macrophages during acute kidney injury.

Authors:  Chongbin Liu; Yanting Shen; Liuwei Huang; Jun Wang
Journal:  Cell Death Discov       Date:  2022-04-26

5.  Macrophage‑derived exosomal miRNA‑155 promotes tubular injury in ischemia‑induced acute kidney injury.

Authors:  Zhijian Zhang; Hanzhi Chen; Leting Zhou; Cheng Li; Guoyuan Lu; Liang Wang
Journal:  Int J Mol Med       Date:  2022-07-07       Impact factor: 5.314

6.  Fucose as a potential therapeutic molecule against the immune-mediated inflammation in IgA nepharopathy: An unrevealed link.

Authors:  Jianbo Qing; Xueli Hu; Changqun Li; Wenzhu Song; Hasna Tirichen; Hasnaa Yaigoub; Yafeng Li
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

7.  Tubular epithelial cell-derived extracellular vesicles induce macrophage glycolysis by stabilizing HIF-1α in diabetic kidney disease.

Authors:  Yijie Jia; Jiaqi Chen; Zhikang Zheng; Yuan Tao; Shuting Zhang; Meina Zou; Yanlin Yang; Meng Xue; Fang Hu; Yang Li; Qian Zhang; Yaoming Xue; Zongji Zheng
Journal:  Mol Med       Date:  2022-08-12       Impact factor: 6.376

Review 8.  Molecular Mechanisms of Cellular Injury and Role of Toxic Heavy Metals in Chronic Kidney Disease.

Authors:  Manish Mishra; Larry Nichols; Aditi A Dave; Elizabeth H Pittman; John P Cheek; Anasalea J V Caroland; Purva Lotwala; James Drummond; Christy C Bridges
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

Review 9.  Macrophage Heterogeneity in Kidney Injury and Fibrosis.

Authors:  Yi Wen; Hong-Ru Yan; Bin Wang; Bi-Cheng Liu
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

10.  Bruton's tyrosine kinase regulates macrophage‑induced inflammation in the diabetic kidney via NLRP3 inflammasome activation.

Authors:  Jing Zhao; Juan Chen; Yuan-Yuan Li; Ling-Ling Xia; Yong-Gui Wu
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.